错误:cAMP在多发性骨髓瘤中诱导细胞亡,并克服对博雷佐米布的耐药性
Yingying Wang1, Yong Tang1, Haifang Hang1
1Department of Hematology, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai 200011, P. R. China.
American journal of cancer research
|May 15, 2025
概括
这项研究纠正了之前的出版物. 校正确保了科学记录的准确性,以确保未来的研究和数据完整性.
科学领域:
- 科学出版业的科学出版.
- 研究完整性研究完整性
背景情况:
- 上一篇文章包含一个错误.
- 确保发表的科学文献的准确性至关重要.
研究的目的:
- 为了纠正以前发表的文章中的错误.
- 维护科学记录的完整性.
主要方法:
- 在原始出版物中识别特定错误.
- 发出正式的纠正通知.
主要成果:
- 第8卷第16页上的错误已正式纠正.
- 正确的文章现在可用,确保数据完整性.
结论:
- 校正对于保持科学出版的高标准至关重要.
- 准确的科学记录支持可靠的未来研究.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...